All news is rigorously fact-checked and reviewed by leading blockchain experts and seasoned industry insiders.
The event of January 10—the SEC decision on Bitcoin ETF—which saw 11 applications for spot Bitcoin ETF approval, including BlackRock’s—continues to make headlines. This historic development represents a significant stride toward mainstream acceptance and adoption of cryptocurrency. Hence, it has gathered widespread acclaim from various sectors.
BlackRock, the world’s largest asset manager, now holds 25,067 BTC, worth billions of dollars, for their spot Bitcoin ETF. This large holding represents a tip of the massive inflow set to enter Bitcoin as the ETF market grows, positioning BTC as one of the best cryptos to invest in.
Meanwhile, Injective (INJ) and InQubeta (QUBE), two top crypto coins, have emerged as investors’ top picks. This is thanks to their solid fundamentals and exceptional growth potential, which this post will cover.
InQubeta (QUBE): Investors’ Top Pick
ICO investments are becoming a popular strategy among investors seeking staggering gains. This is because of their low entry points and the opportunities to enjoy explosive gains. One of the most popular new ICOs currently is InQubeta (QUBE), boasting astounding upside potential and solid fundamentals. At the moment, a staggering $8.4 million has been raised in its early funding, suggesting trust in its potential.
In the seventh stage of the presale, a token costs only $0.0224. Meanwhile, according to analysts, there will be a 65x rally in its price after launch, which positions it as the best new crypto to invest in.
Further, as a blend of AI and blockchain, it is incredibly appealing. It aims to solve one of the most pressing challenges in the AI sector with blockchain, notably fundraising. Hence, its crowdfunding platform will allow tech startups to raise funds through crypto by minting investment opportunities as NFTs and offering them to investors in the marketplace.
BlackRock: 25,067 BTC in Spot ETF
Investing in BTC ETFs marks a monumental milestone in the history of cryptocurrency—a truly remarkable feat. One of the key benefits of Bitcoin ETFs is that they make the digital asset more appealing to investors in the traditional financial landscape. After all, they don’t have to hold the asset before gaining exposure. BlackRock, the world’s largest asset manager, is one of the issuers of spot Bitcoin ETFs after its application was approved by the US SEC on January 10.
At the moment, the asset manager holds a staggering 25,067 BTC for their spot Bitcoin ETF. This is worth billions of dollars, depending on the valuation of the speculative asset. With the Bitcoin ETF market already exceeding expectations—recently surpassing silver as the second-largest commodity ETF in the US—there will be greater inflows in the future.
Injective (INJ): Growth Continues
Injective (INJ) continues its onward charge, giving other top altcoins a run for their money. Following its explosive surge the previous year, those wondering if it could replicate such a feat are quietly observing.
So far into the new year, Injective has been one of the top performers, positioned among the best coins to invest in. Its potential ascent as the year rolls by makes it a bullish play not to miss out on. Further, as one of the most highly sought-after cryptocurrencies, thanks to its solid fundamentals as a blockchain built for finance, it is a good crypto to buy.
Conclusion
With barely two weeks since the Bitcoin ETF market launched, it has been growing at a remarkable pace, and BlackRock now boasts 25,067 BTC for their spot Bitcoin ETF. Meanwhile, Injective and InQubeta have emerged as favorites among investors. With a strong bullish wave to ride, we recommend checking these promising cryptocurrencies out.
